Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10787-018-0512-y.

Title:
Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers | Inflammopharmacology
Description:
Hydroxychloroquine (HCQ) is a widely prescribed medication to patients with systemic lupus erythematosus (SLE), with potential anti-inflammatory effects. This study was performed to investigate the efficacy of HCQ therapy by serial assessment of disease activity and serum levels of proinflammatory cytokines in SLE patients. In this prospective cohort study, 41 newly diagnosed SLE patients receiving 400 mg HCQ per day were included. Patients requiring statins and immunosuppressive drugs except prednisolone at doses lower than 10 mg/day were excluded. Outcome measures were assessed before commencement of HCQ therapy (baseline visit) as well as in two follow-up visits (1 and 2 months after beginning the HCQ therapy). Serum samples of 41 age-matched healthy donors were used as controls. Median levels of IL-1β (p < 0.001), IL-6 (p = 0.001), and TNF-α (p < 0.001) were significantly higher, whereas, median CH50 level was significantly lower (p < 0.001) in SLE patients compared with controls. Two-month treatment with HCQ resulted in significant decrease in SLEDAI-2K (p < 0.001), anti-dsDNA (p < 0.001), IL-1β (p = 0.003), IL-6 (p < 0.001) and TNF-α (p < 0.001) and a significant increase in CH50 levels (p = 0.012). The reductions in SLEDAI-2K and serum levels of IL-1β and TNF-α were significantly greater in the first month compared with the reductions in the second month. HCQ therapy is effective on clinical improvement of SLE patients through interfering with inflammatory signaling pathways, reducing anti-DNA autoantibodies and normalizing the complement activity.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

pubmed, article, lupus, google, scholar, cas, systemic, erythematosus, patients, hydroxychloroquine, disease, activity, central, sle, arthritis, rheum, cytokine, therapy, levels, study, shariatisarabi, cytokines, research, hcq, proinflammatory, treatment, clinical, cells, dis, mashhad, analysis, monzavi, access, effect, rheumatol, ann, university, privacy, cookies, content, alirezaei, serum, related, diseases, nephritis, necrosis, interleukin, authors, medical, sciences,

Topics {✒️}

th1/th2/th17/treg cytokine imbalance anti-tnfalpha monoclonal antibody tumor necrosis factor-alpha month download article/chapter complement system reducing anti-dna autoantibodies jalil tavakol afshari serum cytokine profile potential anti-inflammatory effects zhaleh shariati-sarabi full article pdf cytokine profiles article inflammopharmacology aims outcome measures article monzavi imam reza hospital author information authors systemic lupus erythematosus active lupus nephritis van vollenhoven rf privacy choices/manage cookies buali research institute related diseases banafsheh dormanesh autoantibody clusters interaction ruiz-irastorza pro-inflammatory cytokines faezeh jahandoost dubois’ lupus erythematosus cutaneous lupus erythematosus blood hydroxychloroquine concentration oliveira ps northern indian subjects rheumatic diseases inflammatory signaling pathways check access instant access lupus nephritis european economic area widely prescribed medication leucocyte-binding protein shariati-sarabi lysosomal maturation facilitate igg-coated erythrocytes de rooij hh martinez-martinez la plasmacytoid dendritic cells related subjects article log mahmoud mahmoudi

Questions {❓}

  • Ferraccioli G, Houssiau FA (2013) Which B-cell subset should we target in lupus?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers
         description:Hydroxychloroquine (HCQ) is a widely prescribed medication to patients with systemic lupus erythematosus (SLE), with potential anti-inflammatory effects. This study was performed to investigate the efficacy of HCQ therapy by serial assessment of disease activity and serum levels of proinflammatory cytokines in SLE patients. In this prospective cohort study, 41 newly diagnosed SLE patients receiving 400 mg HCQ per day were included. Patients requiring statins and immunosuppressive drugs except prednisolone at doses lower than 10 mg/day were excluded. Outcome measures were assessed before commencement of HCQ therapy (baseline visit) as well as in two follow-up visits (1 and 2 months after beginning the HCQ therapy). Serum samples of 41 age-matched healthy donors were used as controls. Median levels of IL-1β (p < 0.001), IL-6 (p = 0.001), and TNF-α (p < 0.001) were significantly higher, whereas, median CH50 level was significantly lower (p < 0.001) in SLE patients compared with controls. Two-month treatment with HCQ resulted in significant decrease in SLEDAI-2K (p < 0.001), anti-dsDNA (p < 0.001), IL-1β (p = 0.003), IL-6 (p < 0.001) and TNF-α (p < 0.001) and a significant increase in CH50 levels (p = 0.012). The reductions in SLEDAI-2K and serum levels of IL-1β and TNF-α were significantly greater in the first month compared with the reductions in the second month. HCQ therapy is effective on clinical improvement of SLE patients through interfering with inflammatory signaling pathways, reducing anti-DNA autoantibodies and normalizing the complement activity.
         datePublished:2018-07-10T00:00:00Z
         dateModified:2018-07-10T00:00:00Z
         pageStart:1175
         pageEnd:1182
         sameAs:https://doi.org/10.1007/s10787-018-0512-y
         keywords:
            Complement system proteins
            Cytokines
            Hydroxychloroquine
            Systemic lupus erythematosus
            Treatment outcome
            Pharmacology/Toxicology
            Immunology
            Rheumatology
            Gastroenterology
            Dermatology
            Allergology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0512-y/MediaObjects/10787_2018_512_Fig1_HTML.png
         isPartOf:
            name:Inflammopharmacology
            issn:
               1568-5608
               0925-4692
            volumeNumber:26
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Seyed Mostafa Monzavi
               affiliation:
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aida Alirezaei
               affiliation:
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Zhaleh Shariati-Sarabi
               url:http://orcid.org/0000-0002-9804-4559
               affiliation:
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Jalil Tavakol Afshari
               affiliation:
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mahmoud Mahmoudi
               affiliation:
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Banafsheh Dormanesh
               affiliation:
                     name:AJA University of Medical Sciences
                     address:
                        name:AJA University of Medical Sciences, Tehran, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Faezeh Jahandoost
               affiliation:
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
                     name:Mashhad University of Medical Sciences
                     address:
                        name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ali Reza Khoshdel
               affiliation:
                     name:AJA University of Medical Sciences
                     address:
                        name:AJA University of Medical Sciences, Tehran, Iran
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ali Etemad Rezaie
               affiliation:
                     name:Rosalind Franklin University of Medicine and Science
                     address:
                        name:Rosalind Franklin University of Medicine and Science, North Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers
      description:Hydroxychloroquine (HCQ) is a widely prescribed medication to patients with systemic lupus erythematosus (SLE), with potential anti-inflammatory effects. This study was performed to investigate the efficacy of HCQ therapy by serial assessment of disease activity and serum levels of proinflammatory cytokines in SLE patients. In this prospective cohort study, 41 newly diagnosed SLE patients receiving 400 mg HCQ per day were included. Patients requiring statins and immunosuppressive drugs except prednisolone at doses lower than 10 mg/day were excluded. Outcome measures were assessed before commencement of HCQ therapy (baseline visit) as well as in two follow-up visits (1 and 2 months after beginning the HCQ therapy). Serum samples of 41 age-matched healthy donors were used as controls. Median levels of IL-1β (p < 0.001), IL-6 (p = 0.001), and TNF-α (p < 0.001) were significantly higher, whereas, median CH50 level was significantly lower (p < 0.001) in SLE patients compared with controls. Two-month treatment with HCQ resulted in significant decrease in SLEDAI-2K (p < 0.001), anti-dsDNA (p < 0.001), IL-1β (p = 0.003), IL-6 (p < 0.001) and TNF-α (p < 0.001) and a significant increase in CH50 levels (p = 0.012). The reductions in SLEDAI-2K and serum levels of IL-1β and TNF-α were significantly greater in the first month compared with the reductions in the second month. HCQ therapy is effective on clinical improvement of SLE patients through interfering with inflammatory signaling pathways, reducing anti-DNA autoantibodies and normalizing the complement activity.
      datePublished:2018-07-10T00:00:00Z
      dateModified:2018-07-10T00:00:00Z
      pageStart:1175
      pageEnd:1182
      sameAs:https://doi.org/10.1007/s10787-018-0512-y
      keywords:
         Complement system proteins
         Cytokines
         Hydroxychloroquine
         Systemic lupus erythematosus
         Treatment outcome
         Pharmacology/Toxicology
         Immunology
         Rheumatology
         Gastroenterology
         Dermatology
         Allergology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0512-y/MediaObjects/10787_2018_512_Fig1_HTML.png
      isPartOf:
         name:Inflammopharmacology
         issn:
            1568-5608
            0925-4692
         volumeNumber:26
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Seyed Mostafa Monzavi
            affiliation:
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aida Alirezaei
            affiliation:
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Zhaleh Shariati-Sarabi
            url:http://orcid.org/0000-0002-9804-4559
            affiliation:
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Jalil Tavakol Afshari
            affiliation:
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mahmoud Mahmoudi
            affiliation:
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Banafsheh Dormanesh
            affiliation:
                  name:AJA University of Medical Sciences
                  address:
                     name:AJA University of Medical Sciences, Tehran, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Faezeh Jahandoost
            affiliation:
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
                  name:Mashhad University of Medical Sciences
                  address:
                     name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ali Reza Khoshdel
            affiliation:
                  name:AJA University of Medical Sciences
                  address:
                     name:AJA University of Medical Sciences, Tehran, Iran
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ali Etemad Rezaie
            affiliation:
                  name:Rosalind Franklin University of Medicine and Science
                  address:
                     name:Rosalind Franklin University of Medicine and Science, North Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Inflammopharmacology
      issn:
         1568-5608
         0925-4692
      volumeNumber:26
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Mashhad University of Medical Sciences
      address:
         name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:Mashhad University of Medical Sciences
      address:
         name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:Mashhad University of Medical Sciences
      address:
         name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:Mashhad University of Medical Sciences
      address:
         name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:Mashhad University of Medical Sciences
      address:
         name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:Mashhad University of Medical Sciences
      address:
         name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:Mashhad University of Medical Sciences
      address:
         name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:AJA University of Medical Sciences
      address:
         name:AJA University of Medical Sciences, Tehran, Iran
         type:PostalAddress
      name:Mashhad University of Medical Sciences
      address:
         name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:Mashhad University of Medical Sciences
      address:
         name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
         type:PostalAddress
      name:AJA University of Medical Sciences
      address:
         name:AJA University of Medical Sciences, Tehran, Iran
         type:PostalAddress
      name:Rosalind Franklin University of Medicine and Science
      address:
         name:Rosalind Franklin University of Medicine and Science, North Chicago, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Seyed Mostafa Monzavi
      affiliation:
            name:Mashhad University of Medical Sciences
            address:
               name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
      name:Aida Alirezaei
      affiliation:
            name:Mashhad University of Medical Sciences
            address:
               name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
            name:Mashhad University of Medical Sciences
            address:
               name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Zhaleh Shariati-Sarabi
      url:http://orcid.org/0000-0002-9804-4559
      affiliation:
            name:Mashhad University of Medical Sciences
            address:
               name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
            name:Mashhad University of Medical Sciences
            address:
               name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Jalil Tavakol Afshari
      affiliation:
            name:Mashhad University of Medical Sciences
            address:
               name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
      name:Mahmoud Mahmoudi
      affiliation:
            name:Mashhad University of Medical Sciences
            address:
               name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
      name:Banafsheh Dormanesh
      affiliation:
            name:AJA University of Medical Sciences
            address:
               name:AJA University of Medical Sciences, Tehran, Iran
               type:PostalAddress
            type:Organization
      name:Faezeh Jahandoost
      affiliation:
            name:Mashhad University of Medical Sciences
            address:
               name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
            name:Mashhad University of Medical Sciences
            address:
               name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
               type:PostalAddress
            type:Organization
      name:Ali Reza Khoshdel
      affiliation:
            name:AJA University of Medical Sciences
            address:
               name:AJA University of Medical Sciences, Tehran, Iran
               type:PostalAddress
            type:Organization
      name:Ali Etemad Rezaie
      affiliation:
            name:Rosalind Franklin University of Medicine and Science
            address:
               name:Rosalind Franklin University of Medicine and Science, North Chicago, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
      name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
      name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
      name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
      name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
      name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
      name:Immunology Research Center, Buali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran
      name:AJA University of Medical Sciences, Tehran, Iran
      name:Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
      name:Department of Internal Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
      name:AJA University of Medical Sciences, Tehran, Iran
      name:Rosalind Franklin University of Medicine and Science, North Chicago, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(194)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.22s.